ContraFect
(NASDAQ:CFRX)
$2.90
00
At close: Jun 29
$2.95
0.0500[1.72%]
After Hours: 7:58PM EDT
Day High/Low- - -
52 Week High/Low2.11 - 4.54
Open / Close- / -
Float / Outstanding27.9M / 39.3M
Vol / Avg.- / 128.7K
Mkt Cap114.1M
P/E-
50d Avg. Price3.44
Div / Yield-
Payout Ratio-
EPS-0.11
Total Float27.9M

ContraFect (NASDAQ:CFRX), Quotes and News Summary

ContraFect (NASDAQ: CFRX)

Day High/Low- - -
52 Week High/Low2.11 - 4.54
Open / Close- / -
Float / Outstanding27.9M / 39.3M
Vol / Avg.- / 128.7K
Mkt Cap114.1M
P/E-
50d Avg. Price3.44
Div / Yield-
Payout Ratio-
EPS-0.11
Total Float27.9M
Benzinga - Mar 24, 2022, 8:09AM
Benzinga - Nov 30, 2021, 10:17AM
load more
Sector: Health Care.Industry: Biotechnology
ContraFect Corp is a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections. Its lysin exebacase has a targeted spectrum of activity, meaning that it kills specific species of Staphylococci or closely related bacteria. Its IND candidate, CF-370, targets resistant gram-negative bacteria including Pseudomonas aeruginosa (P. aeruginosa). Its advanced clinical candidate, exebacase, is an investigational novel lysin that targets Staphylococcus aureus (Staph aureus), including methicillin-resistant (MRSA) strains, which causes serious infections such as bacteremia, pneumonia and osteomyelitis.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-12
REV
Q1 2022Est.ActualSurprise
EPS-0.310-0.510 -0.2000
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

ContraFect Questions & Answers

Q
How do I buy ContraFect (CFRX) stock?
A

You can purchase shares of ContraFect (NASDAQ: CFRX) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are ContraFect's (CFRX) competitors?
Q
What is the target price for ContraFect (CFRX) stock?
A

The latest price target for ContraFect (NASDAQ: CFRX) was reported by WBB Securities on Wednesday, June 8, 2022. The analyst firm set a price target for 7.00 expecting CFRX to rise to within 12 months (a possible 141.38% upside). 4 analyst firms have reported ratings in the last year.

Q
Current Stock Price for ContraFect (CFRX)?
A

The stock price for ContraFect (NASDAQ: CFRX) is $2.9 last updated June 29, 2022, 8:00 PM UTC.

Q
Does ContraFect (CFRX) pay a dividend?
A

There are no upcoming dividends for ContraFect.

Q
When is ContraFect (NASDAQ:CFRX) reporting earnings?
A

ContraFect’s Q2 earnings are confirmed for Friday, August 12, 2022.

Q
Is ContraFect (CFRX) going to split?
A

There is no upcoming split for ContraFect.

Q
What sector and industry does ContraFect (CFRX) operate in?
A

ContraFect is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.